Canon Inc. (7751.T) Bundle
Investors seeking a clear, numbers-driven snapshot of Canon Inc. (7751.T) will find cause for close attention in its latest results: Q1 net sales rose 7.1% to ¥1,058.4 billion, driven by a 20% jump in imaging division sales thanks to a 30% surge in network camera sales, while operating profit climbed 20.5% to ¥96.5 billion producing a first-quarter operating margin of 9.1%-the highest Q1 level in 10 years; management now projects full-year net sales of ¥4.74 trillion (up 5.0%) and revised operating income of ¥466 billion with net income of ¥333 billion, even as total assets increased by ¥107.9 billion to ¥5,874.2 billion and total liabilities rose by ¥272.9 billion to ¥2,394.1 billion (pressuring the equity ratio down 3.9 points to 54.7%) amid short-term borrowing to meet working capital needs; analysts remain cautiously optimistic with 4 buy and 11 hold ratings, while risks from Europe, China's property sector, yen appreciation and supply-chain volatility contend with growth vectors such as semiconductor lithography unit gains, new APS-C product launches and robust capital adequacy at Canon Electronics of 85.7%-read on for a line-by-line breakdown of what these figures mean for valuation, liquidity, leverage, and your portfolio positioning
Canon Inc. (7751.T) - Revenue Analysis
Net sales for Q1 FY2025 rose 7.1% year-over-year to ¥1,058.4 billion, reflecting broad-based demand despite a challenging global macro environment. The imaging division led growth with a 20% increase in net sales, underpinned by a 30% jump in network camera sales. Operating profit for Q1 increased 20.5% to ¥96.5 billion, yielding an operating profit ratio of 9.1%. For the full year, Canon projects net sales of ¥4.74 trillion, a 5.0% increase versus the prior year, and expects record sales for the second consecutive year in 2025. More on strategic direction and values can be found here: Mission Statement, Vision, & Core Values (2026) of Canon Inc.- Q1 FY2025 net sales: ¥1,058.4 billion (+7.1% YoY)
- Imaging division net sales: +20% YoY
- Network camera sales: +30% YoY (key driver within imaging)
- Operating profit Q1: ¥96.5 billion (+20.5% YoY); operating profit ratio: 9.1%
- Full-year net sales guidance: ¥4.74 trillion (+5.0% YoY); targeting record sales in 2025
| Metric | Q1 FY2024 | Q1 FY2025 | Change |
|---|---|---|---|
| Net sales (¥ billion) | 987.9 | 1,058.4 | +7.1% |
| Imaging division sales (index) | 100 | 120 | +20% |
| Network camera sales (index) | 100 | 130 | +30% |
| Operating profit (¥ billion) | 80.0 | 96.5 | +20.5% |
| Operating profit ratio | 8.1% | 9.1% | +1.0 pp |
| Full-year net sales guidance (¥ trillion) | 4.51 | 4.74 | +5.0% |
Canon Inc. (7751.T) - Profitability Metrics
Canon Inc. (7751.T) reported a strong start to FY2025 with notable improvements in margin and earnings despite a downward revision to full-year forecasts.- Q1 operating profit rose 20.5% year-over-year to ¥96.5 billion.
- Operating profit ratio improved by 1 percentage point to 9.1% - the highest first-quarter level in 10 years.
- Net income attributable to Canon Inc. for Q1 was ¥72.2 billion, up 20.5% from the prior year.
| Metric | Q1 2025 | Change YoY | Revised Full-Year Forecast |
|---|---|---|---|
| Operating profit | ¥96.5 billion | +20.5% | ¥466 billion (revised from ¥519 billion) |
| Operating profit ratio (Q1) | 9.1% | +1.0 ppt | - |
| Net income (Q1, attributable) | ¥72.2 billion | +20.5% | Full-year ¥333 billion (revised from ¥364 billion) |
- Quarterly performance indicates improved operational efficiency and margin recovery driven by product mix and cost controls.
- Full-year downward revisions (operating income to ¥466B and net income to ¥333B) reflect conservative macro or demand assumptions but remain above analyst expectations, suggesting resilience versus consensus.
- Stronger-than-expected Q1 results provide a buffer against forecast cuts and support near-term cash generation and shareholder-return flexibility.
Canon Inc. (7751.T) - Debt vs. Equity Structure
As of March 31, 2025, Canon Inc. (7751.T) shows a deliberate shift in financing mix driven by increased operational funding needs. Key balance-sheet movements reflect higher leverage through short-term borrowings, offset by reductions in shareholders' equity from capital returns and currency effects.
- Total assets: ¥5,874.2 billion (up ¥107.9 billion vs. prior year-end)
- Total liabilities: ¥2,394.1 billion (up ¥272.9 billion vs. prior year-end)
- Shareholders' equity: ¥3,480.1 billion (down ¥165.0 billion vs. prior year-end)
- Equity ratio: 54.7% (down 3.9 percentage points from 58.6%)
- Canon Electronics Inc. capital adequacy ratio: 85.7% (stable)
| Metric | End of Previous Year | As of Mar 31, 2025 | Change |
|---|---|---|---|
| Total assets (¥bn) | 5,766.3 | 5,874.2 | +107.9 |
| Total liabilities (¥bn) | 2,121.2 | 2,394.1 | +272.9 |
| Shareholders' equity (¥bn) | 3,645.1 | 3,480.1 | -165.0 |
| Equity ratio (%) | 58.6 | 54.7 | -3.9 pp |
| Canon Electronics Inc. capital adequacy (%) | 85.7 | 85.7 | 0.0 |
- Primary driver of liability increase: issuance of short-term loans to meet higher working capital requirements.
- Primary drivers of equity decline: dividend payouts, stock repurchases, and foreign currency translation adjustments.
- Net effect: a lower equity ratio indicates higher financial leverage but retained asset growth.
- Subsidiary strength: Canon Electronics Inc.'s 85.7% capital adequacy ratio underscores robust capital strength at the subsidiary level.
For context on corporate intent and capital allocation priorities, see Mission Statement, Vision, & Core Values (2026) of Canon Inc.
Canon Inc. (7751.T) - Liquidity and Solvency
Canon Inc. shows mixed signals on liquidity and solvency: asset growth and proactive short-term funding have improved near-term liquidity, while rising liabilities and a lower equity ratio point to higher leverage and potential market concern.- Capital adequacy (Canon Electronics Inc.): 85.7% - stable, indicating solid internal risk buffers.
- Total assets: increased by ¥107.9 billion to ¥5,874.2 billion - improved asset base supporting liquidity.
- Total liabilities: increased by ¥272.9 billion to ¥2,394.1 billion - leverage has risen materially.
- Equity ratio: declined to 54.7% - equity share of financing has dipped, affecting solvency perceptions.
- Short-term loans issued to meet working capital needs - indicative of active liquidity management.
- Stable capital adequacy ratio alongside rising liabilities suggests management is balancing growth and risk controls.
| Metric | Amount / Ratio | Change (YoY) |
|---|---|---|
| Total assets | ¥5,874.2 billion | +¥107.9 billion |
| Total liabilities | ¥2,394.1 billion | +¥272.9 billion |
| Equity ratio | 54.7% | Down (to 54.7%) |
| Capital adequacy (Canon Electronics Inc.) | 85.7% | Stable |
| Short-term borrowings | Issued (amounts vary by quarter) | Used for working capital |
- Improved assets and active short-term funding support near-term operational liquidity.
- Higher liabilities and a lower equity ratio increase leverage risk; monitor interest coverage and cash flow generation.
- Stability of the capital adequacy ratio (85.7%) is a positive indicator of risk management despite balance sheet shifts.
Canon Inc. (7751.T) Valuation Analysis
Canon Inc. (7751.T)'s valuation profile reflects steady operational performance, conservative market sentiment, and shareholder-friendly capital allocation.- Analyst sentiment: 4 buy ratings, 11 hold ratings - a cautiously optimistic consensus.
- Projected top-line: Net sales forecast of ¥4.74 trillion for FY2025, indicating revenue growth expectations.
- Profitability outlook: Anticipated operating profit of ¥466 billion for the full year, highlighting operational efficiency.
- Net income: Revised forecast of ¥333 billion, signaling robust bottom-line resilience despite prior cuts.
- Balance sheet strength: Capital adequacy ratio stable at 85.7%, supporting a defensive valuation multiple.
- Capital return policy: Ongoing dividends and share repurchases that can support investor sentiment and valuation floor.
| Metric | Value | Implication |
|---|---|---|
| Analyst Ratings (Buy/Hold) | 4 / 11 | Cautious market view; limited upside priced in |
| Projected Net Sales (FY2025) | ¥4.74 trillion | Revenue growth trajectory |
| Projected Operating Profit (FY2025) | ¥466 billion | Strong operating margin potential |
| Revised Net Income Forecast | ¥333 billion | Resilient profitability |
| Capital Adequacy Ratio | 85.7% | Solid financial foundation; low leverage risk |
| Shareholder Returns | Dividends + Buybacks | Supports valuation and total shareholder return |
Canon Inc. (7751.T) - Risk Factors
Canon Inc. (7751.T) faces a series of interlinked risks that can materially affect near‑term revenues, margins and cash flows. Below is a practical breakdown of the principal risk categories, quantified impact ranges where appropriate (estimates marked), and observable drivers investors should monitor.- Global economic weakness and regional crises
- Currency: yen appreciation
- Competition in imaging and industrial segments
- Raw material and component cost volatility
- Regulatory and compliance risks
- Supply chain and geopolitical disruptions
| Risk | Primary Channel of Impact | Estimated Short‑term Impact (illustrative) | Monitoring Indicators |
|---|---|---|---|
| Global economic slowdown (Europe/China) | Lower demand across office, consumer and industrial sales | Revenue decline 0.5-3.0%; potential ¥15-120B (estimate) | PMI, regional GDP forecasts, order intake trends |
| Yen appreciation | Translation loss on FX, reduced competitiveness | Operating profit reduction est. ¥40-120B per 10% appreciation | JPY/USD, JPY/EUR exchange rates, company FX hedging disclosures |
| Competitive pressure | Price erosion, market share loss | Gross margin compression 0.5-1.5 percentage points in pressured lines | Market share reports, ASP trends, product launch cadence |
| Raw material cost spikes | Higher COGS | Operating margin hit ~0.3-0.7 pp per 5% input cost rise | Commodity indices, supplier price notifications |
| Regulatory changes | Compliance costs, product redesign, potential restrictions | One‑time costs from ¥1B-¥50B+ depending on scope | Regulatory announcements, legal/regulatory filings |
| Supply chain disruption | Production shortfalls, higher logistics expense | Revenue timing shifts; expedited costs can erode margin by several hundred basis points in affected quarters | Shipping lead times, supplier health, inventory days |
- How these risks translate to Canon's financials
- Practical investor signals to watch
Canon Inc. (7751.T) Growth Opportunities
Canon Inc. (7751.T) is positioned to leverage several near- and long-term growth vectors across imaging, industrial, and healthcare domains. Recent segment performance and strategic initiatives point to expanding top-line momentum and margin improvement potential.- Imaging division momentum: net sales rose 20% year-on-year, led by a 30% jump in network camera sales-an indicator of durable demand for both consumer and professional imaging products.
- Semiconductor lithography expansion: unit sales of lithography equipment increased by 10%, signaling growing traction in the semiconductor capital equipment market and a pathway to higher-margin revenue.
- Product roadmap: upcoming launches (including the EOS R50 V and additional APS-C models) are expected to stimulate camera sales and refresh the product mix.
| Metric | Recent Figure / Change |
|---|---|
| Imaging division net sales (YoY) | +20% |
| Network camera sales (YoY) | +30% |
| Semiconductor lithography unit sales (YoY) | +10% |
| R&D expenditure (annual, company-reported level - approximate) | ¥200 billion |
| Dividend yield (approx.) | ~3.5% |
| Share repurchase programs (recent announcement) | ¥100 billion (program size shown by management) |
| High-margin focus areas | Semiconductor lithography, medical devices, industrial imaging |
| Gross margin (recent) | ~33% |
| Operating margin (recent) | ~10% |
- Margin uplift strategy: prioritizing high-margin segments - semiconductor lithography and medical devices - should improve blended profitability as those businesses scale.
- Capital allocation: continued dividends and periodic buybacks reinforce shareholder returns and can support valuation multiples; recent dividend policy and repurchase programs indicate management commitment.
- R&D and innovation: sustained investment in R&D (≈¥200B p.a.) targets advanced imaging, sensor, lithography, and healthcare technologies, enabling capture of emerging industrial and consumer opportunities.
Canon Inc. (7751.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.